Načítá se...
Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy
BACKGROUND: Clear cell sarcoma (CCS) is a rare, aggressive soft tissue sarcoma thought to derive from neural crest and characterized by a 12;22 translocation. The resulting fusion protein directly activates expression of the melanocyte master transcription factor and drives the same down-stream path...
Uloženo v:
| Vydáno v: | Clin Sarcoma Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513342/ https://ncbi.nlm.nih.gov/pubmed/28725344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0079-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|